View in EDS HTML Full Text PDF Full Text

Efficacy of Lenvatinib as Second-Line Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma.

Saved in:
Bibliographic Details
Title: Efficacy of Lenvatinib as Second-Line Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma.
Authors: Takizawa, Daichi1 (AUTHOR), Arai, Hirotaka1,2 (AUTHOR), Shibasaki, Mitsuhiko1,3 (AUTHOR), Tamura, Yuki1,4 (AUTHOR), Kakizaki, Satoru2,5 (AUTHOR) kakizaki@gunma-u.ac.jp, Hatanaka, Takeshi3,6 (AUTHOR), Naganuma, Atsushi4,7 (AUTHOR), Ueno, Takashi5,8 (AUTHOR), Fukuchi, Toru6,9 (AUTHOR), Namikawa, Masashi7,10 (AUTHOR), Takakusagi, Satoshi8,11 (AUTHOR), Saito, Shuichi9 (AUTHOR), Suga, Takayoshi10 (AUTHOR), Tojima, Hiroki11 (AUTHOR), Yamazaki, Yuichi11 (AUTHOR), Uraoka, Toshio11 (AUTHOR)
Source: Current Oncology. Mar2026, Vol. 31 Issue 3, p159. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:11980052
DOI:10.3390/curroncol33030159